Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

August-01-06

FDA Resumes Consideration of Emergency Contraception Over-The-Counter

The Food and Drug Administration (FDA) announced on Monday that it would resume the process of making emergency contraception over-the-counter for some women. Dr. Andrew von Eschenbach, acting commissioner of the FDA, has said FDA officials would like to meet with Barr Laboratories Inc., the manufacturer of the drug, within the next seven days to discuss Barr’s plan to distribute the drug over the counter only to women ages 16 and older while requiring prescription-only access to those 15 and younger. In a letter to Duramed Research, a subsidiary of Barr, von Eschenbach also indicated that the FDA believes only women ages 18 and older should be able to access the drug over the counter, and recommends that Barr resubmit its application to that effect. The announcement came only 24 hours before the Senate Health, Education, Labor, and Pensions Committee began its hearing on von Eschenbach’s nomination to become FDA commissioner.

Despite overwhelming approval from the FDA’s scientific advisory committees, the FDA denied Barr’s application for over-the-counter status for Plan B, a brand of emergency contraception, in 2004. Barr then resubmitted a petition for Plan B to be approved for over-the-counter use for women ages 16 and older, along with an outline of how the age requirement would be enforced. This petition has yet to be approved or denied.

Democrats in the Senate are skeptical of the timing of the announcement, after experiencing two years of inaction in the approval process. “The FDA’s announcement today really is once again a non-decision. We find ourselves at the same place we did a year ago with the administration saying don’t worry, we’re just asking for some more information…trust us,” said Sen. Patty Murray (D-WA) on Monday, according to the Chicago Tribune. Murray and Senator Hillary Rodham (D-NY) have been blocking the confirmation of von Eschenbach until the FDA reaches a decision on over-the-counter Plan B.

Media Resources: Chicago Tribune 7/31/06; Associated Press 7/31/06; Reuters 7/31/06; Philadelphia Inquirer 8/1/06; FDA letter 7/31/06


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

10/22/2014 Students Protest Fordham University's Anti-Birth Control Policy - Students at Fordham University are engaged in a battle against the New York City Catholic school's anti-birth control policy. Students for Sex & Gender Equality and Safety (SAGES) has launched a petition drive, calling on Fordham to provide free and confidential access to birth control and STI testing on-campus, free condoms, professional gynecological services at the university, and resources for pregnant women, among other things. . . .
 
10/22/2014 Doctors Warn That Measure 1 Would End In Vitro Fertilization in North Dakota - Doctors at North Dakota's only clinic offering in vitro fertilization (IVF) are speaking out to warn voters that Measure 1, a proposed personhood amendment in the state, would make the practice illegal. Dr. . . .
 
10/21/2014 Afghanistan's New First Lady Advances Women's Issues - Just a few days after moving to the presidential palace, Afghanistan's new First Lady Rula Ghani said that she hopes to encourage greater respect for women. Rula Ghani already broke tradition by participating in her husband, Ashraf Ghani Ahmadzai's, campaign for President. . . .